Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,498 | 45 | 55.6% |
| Travel and Lodging | $1,197 | 3 | 44.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Olympus Corporation of the Americas | $994.24 | 6 | $0 (2017) |
| AbbVie Inc. | $576.28 | 19 | $0 (2021) |
| Boston Scientific Corporation | $445.66 | 1 | $0 (2019) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $223.09 | 15 | $0 (2019) |
| Intercept Pharmaceuticals, Inc. | $148.45 | 1 | $0 (2019) |
| Synergy Pharmaceuticals Inc | $125.00 | 1 | $0 (2017) |
| Merck Sharp & Dohme Corporation | $122.95 | 1 | $0 (2017) |
| QOL Medical, LLC | $37.72 | 3 | $0 (2017) |
| Endo Pharmaceuticals Inc. | $21.25 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $19.69 | 1 | AbbVie Inc. ($19.69) |
| 2019 | $1,251 | 33 | Boston Scientific Corporation ($445.66) |
| 2018 | $36.33 | 2 | AbbVie, Inc. ($36.33) |
| 2017 | $1,388 | 12 | Olympus Corporation of the Americas ($994.24) |
All Payment Transactions
48 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/03/2021 | AbbVie Inc. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $19.69 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/27/2019 | AbbVie, Inc. | Mavyret (Drug) | Food and Beverage | In-kind items and services | $20.07 | General |
| Category: Virology | ||||||
| 10/02/2019 | AbbVie, Inc. | Mavyret (Drug) | Food and Beverage | In-kind items and services | $22.14 | General |
| Category: Virology | ||||||
| 09/10/2019 | AbbVie, Inc. | Mavyret (Drug) | Food and Beverage | In-kind items and services | $23.06 | General |
| Category: Virology | ||||||
| 08/19/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.56 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/24/2019 | AbbVie, Inc. | Mavyret (Drug) | Food and Beverage | In-kind items and services | $19.50 | General |
| Category: Virology | ||||||
| 07/11/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $19.29 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/11/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.46 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/26/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $7.41 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/11/2019 | AbbVie, Inc. | Mavyret (Drug) | Food and Beverage | In-kind items and services | $23.50 | General |
| Category: Virology | ||||||
| 06/06/2019 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $19.03 | General |
| Category: Immunology | ||||||
| 06/05/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.05 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/21/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.20 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/21/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.94 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/01/2019 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $19.11 | General |
| Category: Immunology | ||||||
| 04/30/2019 | AbbVie, Inc. | Creon (Drug) | Food and Beverage | In-kind items and services | $20.53 | General |
| Category: Endocrinology | ||||||
| 04/29/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.72 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/11/2019 | AbbVie, Inc. | Mavyret (Drug) | Food and Beverage | In-kind items and services | $24.28 | General |
| Category: Virology | ||||||
| 04/10/2019 | Boston Scientific Corporation | CAPTIVATOR (Device) | Travel and Lodging | In-kind items and services | $445.66 | General |
| Category: POLYPECTOMY | ||||||
| 04/04/2019 | AbbVie, Inc. | Creon (Drug) | Food and Beverage | In-kind items and services | $16.23 | General |
| Category: Endocrinology | ||||||
| 04/04/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $7.76 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/28/2019 | Endo Pharmaceuticals Inc. | NASCOBAL (Drug) | Food and Beverage | In-kind items and services | $21.25 | General |
| Category: PRESCRIPTION SUPPLEMENT | ||||||
| 03/25/2019 | AbbVie, Inc. | Mavyret (Drug) | Food and Beverage | In-kind items and services | $24.73 | General |
| Category: Virology | ||||||
| 03/14/2019 | AbbVie, Inc. | Mavyret (Drug) | Food and Beverage | In-kind items and services | $20.08 | General |
| Category: Virology | ||||||
| 02/28/2019 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $148.45 | General |
| Category: HEPATOLOGY GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 397 | 529 | $672,170 | $46,703 |
| 2022 | 10 | 300 | 411 | $523,493 | $31,917 |
| 2021 | 9 | 233 | 321 | $287,610 | $25,152 |
| 2020 | 8 | 150 | 179 | $199,629 | $11,519 |
All Medicare Procedures & Services
42 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 56 | 171 | $63,270 | $10,192 | 16.1% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 53 | 54 | $187,920 | $6,683 | 3.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 37 | 43 | $37,800 | $5,341 | 14.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 61 | 67 | $22,110 | $4,225 | 19.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 37 | 37 | $26,640 | $4,201 | 15.8% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 20 | 20 | $87,000 | $3,823 | 4.4% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 49 | 50 | $132,500 | $3,143 | 2.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 32 | 32 | $18,880 | $3,131 | 16.6% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2023 | 17 | 20 | $40,400 | $1,973 | 4.9% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 11 | 11 | $32,230 | $1,886 | 5.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 13 | 13 | $6,370 | $1,149 | 18.0% |
| 91110 | Imaging of digestive tract done from the inside of the digestive tract | Facility | 2023 | 11 | 11 | $17,050 | $955.02 | 5.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 40 | 130 | $46,150 | $7,099 | 15.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 54 | 69 | $21,597 | $4,389 | 20.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 33 | 33 | $22,671 | $3,843 | 17.0% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 58 | 60 | $152,400 | $3,375 | 2.2% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 20 | 21 | $17,535 | $3,128 | 17.8% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 31 | 31 | $103,850 | $3,042 | 2.9% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 22 | 24 | $13,560 | $2,236 | 16.5% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 12 | 12 | $50,160 | $1,998 | 4.0% |
| 43249 | Balloon dilation of esophagus, stomach, and/or upper small bowel using a flexible endoscope, less than 3.0 cm | Facility | 2022 | 18 | 18 | $73,080 | $1,694 | 2.3% |
| 91110 | Imaging of digestive tract done from the inside of the digestive tract | Facility | 2022 | 12 | 13 | $22,490 | $1,114 | 5.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 48 | 71 | $20,945 | $4,759 | 22.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 29 | 69 | $22,770 | $3,608 | 15.8% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 25 | 25 | $16,125 | $3,028 | 18.8% |
About Dr. Dominic Colella, DO
Dr. Dominic Colella, DO is a Gastroenterology healthcare provider based in Fort Wayne, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/06/2013. The National Provider Identifier (NPI) number assigned to this provider is 1932530680.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Dominic Colella, DO has received a total of $2,695 in payments from pharmaceutical and medical device companies, with $19.69 received in 2021. These payments were reported across 48 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($1,498).
As a Medicare-enrolled provider, Colella has provided services to 1,080 Medicare beneficiaries, totaling 1,440 services with total Medicare billing of $115,291. Data is available for 4 years (2020–2023), covering 42 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Other Specialties Gastroenterology
- Location Fort Wayne, IN
- Active Since 12/06/2013
- Last Updated 11/03/2025
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1932530680
Products in Payments
- EVIS EXERA (Device) $994.24
- CAPTIVATOR (Device) $445.66
- Mavyret (Drug) $303.97
- XIFAXAN (Drug) $223.09
- Creon (Drug) $161.76
- OCALIVA (Drug) $148.45
- Trulance (Drug) $125.00
- DIFICID (Drug) $122.95
- Humira (Biological) $90.86
- Sucraid (Drug) $37.72
- NASCOBAL (Drug) $21.25
- LINZESS (Drug) $19.69
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Fort Wayne
Dr. Efesomwan Aisien, M.d, M.D
Gastroenterology — Payments: $89,557
Dr. Abdo Saad, Md, MD
Gastroenterology — Payments: $59,492
Melissa Garrett, Md, MD
Gastroenterology — Payments: $59,090
Dr. Mariajose Rojas De Leon, Md, MD
Gastroenterology — Payments: $39,782
Dr. Kirsten Weiser, M.d, M.D
Gastroenterology — Payments: $20,935
Dr. David Gutman, Md, Facg, MD, FACG
Gastroenterology — Payments: $13,732